Bassel El-Rayes, MD, discusses the key points physicians should consider when treating a patient with metastatic colorectal cancer.
Bassel El-Rayes, MD, chief clinical research scientist, Winship Cancer Institute of Emory University, discusses the key points physicians should consider when treating a patient with metastatic colorectal cancer (mCRC).
The first thing is the importance of multidisciplinary care, says El-Rayes. Patients with mCRC need to be discussed in a tumor board and multiple specialties should be included in the discussion in order to form the best treatment plan. Physicians should be aware of all the advantages to different therapies available, such as surgery, radiofrequency ablation, microwave ablation, radiation, and transcatheter therapies.
Retrospective Data Highlight Impact of Dose Escalation of Regorafenib in mCRC
May 9th 2024During a Case-Based Roundtable® event, Madappa Kundranda, MD, PhD, discussed recent retrospective studies that looked at outcomes of dose optimization of regorafenib for patients with relapsed/refractory advanced colorectal cancer in the first article of a 2-part series.
Read More